Toosendanin induces apoptosis through suppression of JNK signaling pathway in HL-60 cells

被引:63
作者
Ju, Jianming [1 ,2 ,3 ]
Qi, Zhichao [1 ,2 ]
Cai, Xueting [3 ]
Cao, Peng [3 ]
Liu, Nan [1 ,2 ]
Wang, Shuzhen [1 ,2 ]
Chen, Yijun [1 ,2 ]
机构
[1] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, Biol Chem Lab, Nanjing 210009, Jiangsu, Peoples R China
[3] Jiangsu Prov Acad Tradit Chinese Med, Dept Pharmaceut Anal & Metabol, Nanjing 210028, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Toosendanin; HL-60; Cell cycle arrest; Apoptosis; JNK signaling pathway; CANCER-CELLS; MAP KINASES; ACTIVATION; INHIBITION; GROWTH; PROLIFERATION; EXPRESSION; LARVAE;
D O I
10.1016/j.tiv.2012.09.013
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 [卫生毒理学];
摘要
Toosendanin (TSN), a triterpenoid isolated from Melia toosendan Sieb. et Zucc., has been found to suppress proliferation and induce apoptosis in a variety of human cancer cells. However, the mechanism how TSN induces apoptosis remains poorly understood. In this study, we examined the effects of TSN on the growth, cell cycle arrest, induction of apoptosis and the involved signaling pathway in human promyelocytic leukemia HL-60 cells. Proliferation of HL-60 cells was inhibited in a dose-dependent manner with the IC50 ((48h)) of 28 ng/mL. The growth inhibition was due primarily to the S phase arrest and cell apoptosis. Cell apoptosis induced by TSN was confirmed by Annexin V-FITC/propidium iodide staining. The increase of the pro-apoptotic protein Bax, cleaved PARP and caspase-3, and the decrease of anti-apoptotic protein Bcl-2 were observed. Western blot analysis indicated that TSN inhibits the CDC42/MEKK1/JNK pathway. Taken together, our study suggested, for the first time, that the pro-apoptotic effects of TSN on HL-60 cells were mediated through JNK signaling pathway. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:232 / 238
页数:7
相关论文
共 33 条
[1]
Growth Inhibition and Induction of Apoptosis in SHG-44 Glioma Cells by Chinese Medicine Formula "Pingliu Keli" [J].
Cao, Peng ;
Cai, Xueting ;
Lu, Wuguang ;
Zhou, Fei ;
Huo, Jiege .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2011, 2011 :1-9
[2]
Antifeedant and insecticide properties of a limonoid from Melia azedarach (Meliaceae) with potential use for pest management [J].
Carpinella, MC ;
Defago, MT ;
Valladares, G ;
Palacios, SM .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2003, 51 (02) :369-374
[3]
Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562 [J].
Chan, Kin Tak ;
Li, Kwan ;
Liu, Shiu Lam ;
Chu, Kee Hung ;
Toh, Melvin ;
Xie, Wei Dong .
CANCER LETTERS, 2010, 289 (01) :46-52
[4]
Chung C.-C., 1975, ACTA CHIM SINICA, V33, P35
[5]
JNK pathway: diseases and therapeutic potential [J].
Cui, Jie ;
Zhang, Ming ;
Zhang, Yong-qing ;
Xu, Zhi-heng .
ACTA PHARMACOLOGICA SINICA, 2007, 28 (05) :601-608
[6]
Signal transduction by the JNK group of MAP kinases [J].
Davis, RJ .
CELL, 2000, 103 (02) :239-252
[7]
Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity - Evidence that mitotic Bcl-2 phosphorylation is JNK-independent [J].
Du, LH ;
Lyle, CS ;
Obey, TB ;
Gaarde, WA ;
Muir, JA ;
Bennett, BL ;
Chambers, TC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (12) :11957-11966
[8]
Toosendanin Inhibits Hepatocellular Carcinoma Cells by Inducing Mitochondria-dependent Apoptosis [J].
He, Yujuan ;
Wang, Jin ;
Liu, XiaoLing ;
Zhang, Ling ;
Yi, Gang ;
Li, Chenwei ;
He, Xiao ;
Wang, Peng ;
Jiang, Hui .
PLANTA MEDICA, 2010, 76 (13) :1447-1453
[9]
Biologic sequelae of c-Jun NH2-terminal kinase (JNK) activation in multiple myeloma cell lines [J].
Hideshima, T ;
Hayashi, T ;
Chauhan, D ;
Akiyama, M ;
Richardson, P ;
Anderson, K .
ONCOGENE, 2003, 22 (54) :8797-8801
[10]
Role of JNK in Tumor Development [J].
Kennedy, Norman J. ;
Davis, Roger J. .
CELL CYCLE, 2003, 2 (03) :199-201